99m Tc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma.
Nan LiXin ZhouHua ZhuFei WangRui GuoYan ZhangYufei SongShizhen ZhaiQing XieJiayong LiuZhongwu LiZhi YangPublished in: Annals of nuclear medicine (2022)
Tc-rituximab could identify SLNs specifically in SLN lymphoscintigraphy and SLNB in CMM patients, and the pathology obtained from SLNB rather than from RLND better indicated the staging and long-term prognosis.
Keyphrases
- sentinel lymph node
- lymph node
- early stage
- neoadjuvant chemotherapy
- end stage renal disease
- diffuse large b cell lymphoma
- newly diagnosed
- ejection fraction
- ultrasound guided
- peritoneal dialysis
- hodgkin lymphoma
- high resolution
- prognostic factors
- radiation therapy
- squamous cell carcinoma
- locally advanced
- patient reported outcomes
- fine needle aspiration
- rectal cancer